In vivo relationships between the cerebral pharmacokinetics and pharmacodynamics of thiopentone in sheep after short-term administration Richard N. UptonGuy L. LudbrookElke C. Gray OriginalPaper 23 February 1996 Pages: 1 - 18
The kinetics of continuously infused indocyanine green in the pig Peter OttLudvik BassSusanne Keiding OriginalPaper 19 February 1996 Pages: 19 - 44
An extended pharmacokinetic/pharmacodynamic model describing quantitatively the influence of plasma protein binding, tissue binding, and receptor binding on the potency and time course of action of drugs Johannes H. ProostJ. Mark K. H. WierdaDirk K. F. Meijer OriginalPaper 30 January 1996 Pages: 45 - 77
Multiple solutions, illegal parameter values, local minima of the sum of squares, and anomalous parameter estimates in least-squares fitting of the two-compartment pharmacokinetic model with absorption R. D. Purves Pharmacometrics 08 February 1996 Pages: 79 - 101
Bayesian individualization via sampling-based methods Jon Wakefield Pharmacometrics 01 February 1996 Pages: 103 - 131
Towards a practical strategy for assessing individual bioequivalence Robert SchallRoger L. WilliamsFood and Drug Administration Individual Bioequivalence Working Group Commentary 21 February 1996 Pages: 133 - 149